Q3 2014 13F Holders as of 9/30/2014
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
49.7M
-
Number of holders
-
254
-
Total 13F shares, excl. options
-
46.7M
-
Shares change
-
-1.52M
-
Total reported value, excl. options
-
$2.79B
-
Value change
-
-$86M
-
Put/Call ratio
-
0.06
-
Number of buys
-
91
-
Number of sells
-
-159
-
Price
-
$59.74
Significant Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) as of Q3 2014
287 filings reported holding CRL - CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share as of Q3 2014.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock, $0.01 par value per share (CRL) has 254 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 46.7M shares
of 49.7M outstanding shares and own 94.04% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.87M shares), WELLINGTON MANAGEMENT CO LLP (3.43M shares), ARIEL INVESTMENTS, LLC (2M shares), ACADIAN ASSET MANAGEMENT LLC (1.81M shares), Invesco Ltd. (1.74M shares), PRIMECAP MANAGEMENT CO/CA/ (1.69M shares), Fairpointe Capital LLC (1.68M shares), BlackRock Fund Advisors (1.39M shares), BlackRock Institutional Trust Company, N.A. (1.33M shares), and State Street Corp (1.32M shares).
This table shows the top 254 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.